Abstract
International guidelines uniformly suggest no routine staging of bone metastasis in patients with bone scintigraphy (BS) in low-risk prostate cancer (PCa). These recommendations are based on retrospective investigations only. In addition, BS has most often been reported as a definitive investigation with no room for equivocal cases.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Nuclear Medicine |
Vol/bind | 39 |
Udgave nummer | 1 |
Sider (fra-til) | 26-31 |
Antal sider | 6 |
ISSN | 0363-9762 |
DOI | |
Status | Udgivet - 2014 |